266 related articles for article (PubMed ID: 17882957)
21. Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach.
Bhandari SV; Bothara KG; Patil AA; Chitre TS; Sarkate AP; Gore ST; Dangre SC; Khachane CV
Bioorg Med Chem; 2009 Jan; 17(1):390-400. PubMed ID: 19036593
[TBL] [Abstract][Full Text] [Related]
22. Novel naftopidil-related derivatives and their biological effects as alpha1-adrenoceptors antagonists and antiproliferative agents.
Huang J; He F; Huang M; Liu X; Xiong Y; Huang Y; Zhu L; Yang Y; Xu X; Yuan M
Eur J Med Chem; 2015; 96():83-91. PubMed ID: 25874333
[TBL] [Abstract][Full Text] [Related]
23. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X.
Badawneh M; Ferrarini PL; Calderone V; Manera C; Martinotti E; Mori C; Saccomanni G; Testai L
Eur J Med Chem; 2001; 36(11-12):925-34. PubMed ID: 11755235
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, vasorelaxant activity and antihypertensive effect of benzo[d]imidazole derivatives.
Navarrete-Vázquez G; Hidalgo-Figueroa S; Torres-Piedra M; Vergara-Galicia J; Rivera-Leyva JC; Estrada-Soto S; León-Rivera I; Aguilar-Guardarrama B; Rios-Gómez Y; Villalobos-Molina R; Ibarra-Barajas M
Bioorg Med Chem; 2010 Jun; 18(11):3985-91. PubMed ID: 20451399
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity.
Malawska B; Kulig K; Gippert A; Filipek B; Sapa J; Maciag D
Farmaco; 2005 Oct; 60(10):793-803. PubMed ID: 16181628
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonists.
Morytko MJ; Betschmann P; Woller K; Ericsson A; Chen H; Donnelly-Roberts DL; Namovic MT; Jarvis MF; Carroll WA; Rafferty P
Bioorg Med Chem Lett; 2008 Mar; 18(6):2093-6. PubMed ID: 18272365
[TBL] [Abstract][Full Text] [Related]
28. Non-imidazole histamine H3 ligands, part IV: SAR of 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives.
Frymarkiewicz A; Walczyński K
Eur J Med Chem; 2009 Apr; 44(4):1674-81. PubMed ID: 18990469
[TBL] [Abstract][Full Text] [Related]
29. Ligand design and synthesis of new imidazo[5,1-b]quinazoline derivatives as alpha1-adrenoceptor agonists and antagonists.
Ismail MA; Aboul-Enein MN; Abouzid KA; Serya RA
Bioorg Med Chem; 2006 Feb; 14(4):898-910. PubMed ID: 16337797
[TBL] [Abstract][Full Text] [Related]
30. The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors.
Smith G; Ruhland T; Mikkelsen G; Andersen K; Christoffersen CT; Alifrangis LH; Mørk A; Wren SP; Harris N; Wyman BM; Brandt G
Bioorg Med Chem Lett; 2004 Aug; 14(15):4027-30. PubMed ID: 15225720
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of 3-arylpiperazinylalkylpyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as novel, potent, and selective alpha1-adrenoceptor ligands.
Patanè E; Pittalà V; Guerrera F; Salerno L; Romeo G; Siracusa MA; Russo F; Manetti F; Botta M; Mereghetti I; Cagnotto A; Mennini T
J Med Chem; 2005 Apr; 48(7):2420-31. PubMed ID: 15801833
[TBL] [Abstract][Full Text] [Related]
32. SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.
Handzlik J; Bojarski AJ; Satała G; Kubacka M; Sadek B; Ashoor A; Siwek A; Więcek M; Kucwaj K; Filipek B; Kieć-Kononowicz K
Eur J Med Chem; 2014 May; 78():324-39. PubMed ID: 24691057
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and 5-HT2A, 5-HT1A and alpha1-binding affinities of 2-[2-Hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-hydroxy-3-(2-pyridin-2-yl-ethyl)amino]- and 2-[2-hydroxy-3-(4-N-methyl-piperazin-1-yl)-amino]propoxybenzaldehyde-O-(substituted) benzyl oximes.
Orlandini E; Rapposelli S; Nencetti S; Giannaccini G; Betti L; Balsamo A
Arch Pharm (Weinheim); 2007 Mar; 340(3):135-9. PubMed ID: 17335104
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines.
Behrouzi-Fardmoghadam M; Poorrajab F; Ardestani SK; Emami S; Shafiee A; Foroumadi A
Bioorg Med Chem; 2008 Apr; 16(8):4509-15. PubMed ID: 18321711
[TBL] [Abstract][Full Text] [Related]
35. Design of new potent and selective secretory phospholipase A2 inhibitors. Part 5: synthesis and biological activity of 1-alkyl-4-[4,5-dihydro-1,2,4-[4H]-oxadiazol-5-one-3-ylmethylbenz-4'-yl(oyl)] piperazines.
Boukli L; Touaibia M; Meddad-Belhabich N; Djimdé A; Park CH; Kim JJ; Yoon JH; Lamouri A; Heymans F
Bioorg Med Chem; 2008 Feb; 16(3):1242-53. PubMed ID: 17993277
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological activity of some 1,3-dihydro-2H-3-benzazepin-2-ones with a piperazine moiety as bradycardic agents.
Liang HY; Zhang DQ; Yue Y; Shi Z; Zhao SY
Arch Pharm (Weinheim); 2010 Feb; 343(2):114-9. PubMed ID: 20108265
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and cardiovascular activity of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3- piperazinopropyl)-3,7-dihydro-1H-purine-2,6-diones.
Chłoń-Rzepa G; Pawłowski M; Zygmunt M; Filipek B; Maciag D
Pol J Pharmacol; 2004; 56(6):755-66. PubMed ID: 15662088
[TBL] [Abstract][Full Text] [Related]
38. 1-[(Imidazolidin-2-yl)imino]indazole. Highly alpha 2/I1 selective agonist: synthesis, X-ray structure, and biological activity.
Saczewski F; Kornicka A; Rybczyńska A; Hudson AL; Miao SS; Gdaniec M; Boblewski K; Lehmann A
J Med Chem; 2008 Jun; 51(12):3599-608. PubMed ID: 18517187
[TBL] [Abstract][Full Text] [Related]
39. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
[TBL] [Abstract][Full Text] [Related]
40. Synthetic study of VLA-4/VCAM-1 inhibitors: synthesis and structure-activity relationship of piperazinylphenylalanine derivatives.
Saku O; Ohta K; Arai E; Nomoto Y; Miura H; Nakamura H; Fuse E; Nakasato Y
Bioorg Med Chem Lett; 2008 Feb; 18(3):1053-7. PubMed ID: 18160288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
